Permeability of the blood-brain barrier to amylin
- PMID:7475950
- DOI: 10.1016/0024-3205(95)02197-q
Permeability of the blood-brain barrier to amylin
Abstract
Amylin is co-secreted with insulin from the pancreas of patients with non-insulin dependent diabetes mellitus, and its deposition may contribute to the central nervous system (CNS) manifestations of this disease. Amylin, but not its mRNA, is found in brain, suggesting that CNS amylin is derived from the circulation. This would require amylin to cross the blood-brain barrier (BBB). We used multiple-time regression analysis to determine the unidirectional influx constant (Ki) of blood-borne, radioactively labeled amylin (I-Amy) into the brain of mice. The Ki was 8.99(10(-4)) ml/g-min and was not inhibited with doses up to 100 micrograms/kg, but it was inhibited by aluminum (Al). About 0.11 to 0.13 percent of the injected dose of I-Amy entered each gram of brain. Radioactivity recovered from brain and analyzed by HPLC showed that the majority of radioactivity taken up by the brain represented intact I-Amy. Capillary depletion confirmed that blood-borne I-Amy completely crossed the BBB to enter the parenchymal/interstitial fluid space of the cerebral cortex. Taken together, these results show that blood-borne amylin has access to brain tissue and may be involved in some of the CNS manifestations of diabetes mellitus.
Similar articles
- Differential permeability of the blood-brain barrier to two pancreatic peptides: insulin and amylin.Banks WA, Kastin AJ.Banks WA, et al.Peptides. 1998;19(5):883-9. doi: 10.1016/s0196-9781(98)00018-7.Peptides. 1998.PMID:9663454
- Regional variation in transport of pancreatic polypeptide across the blood-brain barrier of mice.Banks WA, Kastin AJ, Jaspan JB.Banks WA, et al.Pharmacol Biochem Behav. 1995 May;51(1):139-47. doi: 10.1016/0091-3057(94)00412-c.Pharmacol Biochem Behav. 1995.PMID:7617725
- Transport of insulin across the blood-brain barrier: saturability at euglycemic doses of insulin.Banks WA, Jaspan JB, Huang W, Kastin AJ.Banks WA, et al.Peptides. 1997;18(9):1423-9. doi: 10.1016/s0196-9781(97)00231-3.Peptides. 1997.PMID:9392846
- Amylin and the amylin gene: structure, function and relationship to islet amyloid and to diabetes mellitus.Cooper GJ, Day AJ, Willis AC, Roberts AN, Reid KB, Leighton B.Cooper GJ, et al.Biochim Biophys Acta. 1989 Dec 14;1014(3):247-58. doi: 10.1016/0167-4889(89)90220-6.Biochim Biophys Acta. 1989.PMID:2690958Review.
- [Amylin/IAPP (islet amyloid polypeptide)--physiology and clinical significance].Ludvik B.Ludvik B.Wien Klin Wochenschr. 1997 Jun 6;109(11):379-83.Wien Klin Wochenschr. 1997.PMID:9281227Review.German.
Cited by
- Amylin acts in the central nervous system to increase sympathetic nerve activity.Fernandes-Santos C, Zhang Z, Morgan DA, Guo DF, Russo AF, Rahmouni K.Fernandes-Santos C, et al.Endocrinology. 2013 Jul;154(7):2481-8. doi: 10.1210/en.2012-2172. Epub 2013 May 3.Endocrinology. 2013.PMID:23645151Free PMC article.
- Contraction of human brain vascular pericytes in response to islet amyloid polypeptide is reversed by pramlintide.Nuñez-Diaz C, Pocevičiūtė D, Schultz N; Netherlands Brain Bank; Welinder C, Swärd K, Wennström M.Nuñez-Diaz C, et al.Mol Brain. 2023 Feb 15;16(1):25. doi: 10.1186/s13041-023-01013-1.Mol Brain. 2023.PMID:36793056Free PMC article.
- Gut hormones such as amylin and GLP-1 in the control of eating and energy expenditure.Lutz TA.Lutz TA.Int J Obes Suppl. 2016 Dec;6(Suppl 1):S15-S21. doi: 10.1038/ijosup.2016.4. Epub 2016 Nov 16.Int J Obes Suppl. 2016.PMID:28685025Free PMC article.Review.
- Cyclic AC253, a novel amylin receptor antagonist, improves cognitive deficits in a mouse model of Alzheimer's disease.Soudy R, Patel A, Fu W, Kaur K, MacTavish D, Westaway D, Davey R, Zajac J, Jhamandas J.Soudy R, et al.Alzheimers Dement (N Y). 2016 Dec 10;3(1):44-56. doi: 10.1016/j.trci.2016.11.005. eCollection 2017 Jan.Alzheimers Dement (N Y). 2016.PMID:29067318Free PMC article.
- Amylin Acts in the Lateral Dorsal Tegmental Nucleus to Regulate Energy Balance Through Gamma-Aminobutyric Acid Signaling.Reiner DJ, Mietlicki-Baase EG, Olivos DR, McGrath LE, Zimmer DJ, Koch-Laskowski K, Krawczyk J, Turner CA, Noble EE, Hahn JD, Schmidt HD, Kanoski SE, Hayes MR.Reiner DJ, et al.Biol Psychiatry. 2017 Dec 1;82(11):828-838. doi: 10.1016/j.biopsych.2016.12.028. Epub 2017 Jan 10.Biol Psychiatry. 2017.PMID:28237459Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources